Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Gabapentin borderline personality disorder tardive dyskinesia use in patients with hepatic impairment
gabapentinoids (GABA analogues), addiction/physical dependence and withdrawal
Galactorrhea
Galantamine alzheimerâ™s disease mild cognitive impairment
Gambling disorder
gamma-glutamyl transferase (GGT), psychotropic agent effects
gamma-hydroxybutyrate (GHB) and gamma-butyrolactone dependence planned elective withdrawal unplanned withdrawal withdrawal management withdrawal syndrome
gastrointestinal bleeding, SSRI risks
Gastrointestinal disorders, drug safety in older patients/dementia
Gastrointestinal disturbances, antiretrovirals
Gastrointestinal hypomotility, clozapine-induced
Gastrointestinal irritant drugs, increased risk of bleeding in hepatic impairment
Gastrointestinal necrosis
gastro-oesophageal reflux disease (GERD) 220
General Guidelines
generalised anxiety disorder (GAD) NICE guidelines pregabalin specific drugs used SSRIs/SNRIs valproate treatment
Generalised seizures, severe alcohol withdrawal
General Medical Council, UK, guidelines for prescribers, medical conditions and safe driving
General recommendations for prescribing intramuscular clozapine
Genetics of cytochrome function
Genetic testing for clozapine treatment
Genetic testing for treatment agranulocytosis benign ethnic neutropenia Genetic testing for clozapine treatment
genitourinary symptoms of menopause (GSM) 857
Gestational diabetes, antipsychotics risk
Ginkgo biloba Alternatives to clozapine Dementia Optimising clozapine treatment Treatment of tardive dyskinesia
glomerular filtration rate (GFR), estimation for renal impairment assessment
Glucocorticoid receptor blocking, psychotic depression treatment
Glucose homeostasis antidepressant effects SSRIs improving control
Glucose homeostasis effects
Glucose in blood, psychotropic agent effects